Ionic Diode-Based Drug Delivery System

© 2024 Wiley‐VCH GmbH.

Détails bibliographiques
Publié dans:Advanced materials (Deerfield Beach, Fla.). - 1998. - (2024) vom: 24. Dez., Seite e2412377
Auteur principal: Yoo, Hyunjae (Auteur)
Autres auteurs: Kang, Soon-Bo, Kim, Jeongsoo, Cho, Wonkyung, Ha, Hyojeong, Oh, Seyoung, Jeong, Seol-Ha, Lee, Sihwan, Lee, Hyemin, Park, Chang Seo, Lee, Dong-Yup, Chung, Taek Dong, Lee, Kyung-Mi, Sun, Jeong-Yun
Format: Article en ligne
Langue:English
Publié: 2024
Accès à la collection:Advanced materials (Deerfield Beach, Fla.)
Sujets:Journal Article active drug delivery system flow‐free hydrogel‐based device immune toxicity ionic diode
LEADER 01000caa a22002652c 4500
001 NLM382042387
003 DE-627
005 20250307023318.0
007 cr uuu---uuuuu
008 241224s2024 xx |||||o 00| ||eng c
024 7 |a 10.1002/adma.202412377  |2 doi 
028 5 2 |a pubmed25n1272.xml 
035 |a (DE-627)NLM382042387 
035 |a (NLM)39718239 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Yoo, Hyunjae  |e verfasserin  |4 aut 
245 1 0 |a Ionic Diode-Based Drug Delivery System 
264 1 |c 2024 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Revised 24.12.2024 
500 |a published: Print-Electronic 
500 |a Citation Status Publisher 
520 |a © 2024 Wiley‐VCH GmbH. 
520 |a Drug delivery systems hold promise for delivering cytotoxic drugs by controlling the timing and location of the drug release. However, conventional delivery mechanisms often fall short of achieving spatiotemporally controlled yet sustained release, which is crucial for ensuring drug efficacy and minimizing impact on surrounding tissues. Here, an ionic diode-based drug delivery system is reported that is controlled by an electric potential and capable of releasing drugs at scales ranging from nanogram to microgram. The migrated drug is slowly but continuously diffused to the lesion through the hydrogel at the desired rate. The ionic diode provides flow-free drug delivery while minimizing unintended drug leakage over prolonged periods. Implanted in a freely moving tumor-bearing mouse model, the system filled with doxorubicin demonstrated superior anti-tumor efficacy and minimal off-target immune toxicity compared to the intratumoral injection of free doxorubicin. With its mechanically compliant and biocompatible components, the system offers a safe and readily translatable approach to patients with surgically unresectable tumors 
650 4 |a Journal Article 
650 4 |a active drug delivery system 
650 4 |a flow‐free 
650 4 |a hydrogel‐based device 
650 4 |a immune toxicity 
650 4 |a ionic diode 
700 1 |a Kang, Soon-Bo  |e verfasserin  |4 aut 
700 1 |a Kim, Jeongsoo  |e verfasserin  |4 aut 
700 1 |a Cho, Wonkyung  |e verfasserin  |4 aut 
700 1 |a Ha, Hyojeong  |e verfasserin  |4 aut 
700 1 |a Oh, Seyoung  |e verfasserin  |4 aut 
700 1 |a Jeong, Seol-Ha  |e verfasserin  |4 aut 
700 1 |a Lee, Sihwan  |e verfasserin  |4 aut 
700 1 |a Lee, Hyemin  |e verfasserin  |4 aut 
700 1 |a Park, Chang Seo  |e verfasserin  |4 aut 
700 1 |a Lee, Dong-Yup  |e verfasserin  |4 aut 
700 1 |a Chung, Taek Dong  |e verfasserin  |4 aut 
700 1 |a Lee, Kyung-Mi  |e verfasserin  |4 aut 
700 1 |a Sun, Jeong-Yun  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Advanced materials (Deerfield Beach, Fla.)  |d 1998  |g (2024) vom: 24. Dez., Seite e2412377  |w (DE-627)NLM098206397  |x 1521-4095  |7 nnas 
773 1 8 |g year:2024  |g day:24  |g month:12  |g pages:e2412377 
856 4 0 |u http://dx.doi.org/10.1002/adma.202412377  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |j 2024  |b 24  |c 12  |h e2412377